Form 4: UHS Exec Peterson Reports RSU Vesting, Share Sale

Sentiment:

Insider Transaction Report


Universal Health Services Executive Vice President Matthew Jay Peterson reported the vesting of performance-based restricted stock units and a subsequent sale of shares for tax purposes.

Summary

  • Matthew Jay Peterson, Executive Vice President of Universal Health Services Inc. (UHS), reported changes in his beneficial ownership of Class B Common Stock.
  • On March 12, 2026, Peterson acquired 13,181 shares of Class B Common Stock at a price of $0.
  • These shares were issued upon the vesting of performance-based restricted stock units (RSUs) awarded on March 15, 2023, due to the Issuer's satisfaction of certain performance criteria.
  • On the same date, Peterson disposed of 5,669 shares of Class B Common Stock at a price of $190.49 per share.
  • This disposition is typically for tax withholding obligations related to the RSU vesting.
  • Following these transactions, Peterson beneficially owns 27,477.2263 shares of Class B Common Stock.
  • The total beneficial ownership includes 591.2263 shares purchased at a discounted rate through the Universal Health Services 2005 Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as the vesting of performance-based RSUs indicates the company met its performance targets, which is generally a good sign for investors, despite the subsequent tax-related share sale.

Positives

  • Vesting of 13,181 performance-based restricted stock units indicates the company met specific performance criteria.
  • The RSU vesting at a $0 acquisition price represents a significant gain for the executive.

Negatives

  • Disposition of 5,669 shares, although for tax purposes, reduces the executive's direct holdings.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock ownership changes. The vesting of performance-based RSUs is a common compensation practice in the healthcare industry, aligning executive incentives with company performance.

Comparison to Industry Standards

  • Form 4 filings are standard regulatory disclosures for insider transactions across all industries.
  • The vesting of performance-based RSUs is a common executive compensation structure, similar to practices at other large healthcare providers like HCA Healthcare (HCA) or Tenet Healthcare (THC), where executive compensation often includes equity awards tied to financial or operational performance metrics.

Stakeholder Impact

  • Shareholders: The vesting of performance-based RSUs suggests the company achieved certain performance goals, which could be viewed positively. The executive's continued ownership aligns interests.
  • Employees: The mention of the Employee Stock Purchase Plan indicates a broader employee benefit program.

Key Dates

DateDescription
03/15/2023Award date of performance-based restricted stock units to Matthew Jay Peterson.
03/12/2026Date of RSU vesting and subsequent share acquisition and disposition.
03/13/2026Signature date of the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving the vesting of performance-based restricted stock units and a subsequent sale of shares for tax withholding. While the RSU vesting indicates the company met performance targets, which is a positive signal, the transaction itself does not provide new fundamental information to warrant a change in investment thesis. It's a standard compensation event for an executive, suggesting a 'hold' position as it neither significantly strengthens nor weakens the investment case based solely on this filing.

Keywords

Universal Health Services, UHS, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Sale, Employee Stock Purchase Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.